Comparative Effectiveness Research On Track To Be Resolved In Conference
This article was originally published in The Pink Sheet Daily
Executive Summary
Independent versus government-based CER group is one of issues likely to be left to House/Senate negotiators.
You may also be interested in...
CER And Personalized Medicine Are "Synergistic" - FDA's Woodcock
The goals of comparative effectiveness research and personalized medicine might appear at odds or at least as leading to divergent paths, with one focusing on the best treatment for a population and the other on the best treatment for an individual
CER And Personalized Medicine Are "Synergistic" - FDA's Woodcock
The goals of comparative effectiveness research and personalized medicine might appear at odds or at least as leading to divergent paths, with one focusing on the best treatment for a population and the other on the best treatment for an individual
Merged House Health Bill Seeks More Part D Drug Savings, Sets Broad Medicaid Expansion
Many of the bill's provisions specifically related to the biopharmaceutical industry are relatively unchanged from earlier versions that emerged from three House committees.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: